Indian Tax-Free Zones Split Drug Makers Over Excise Tax Cuts
This article was originally published in PharmAsia News
Although the organization representing India's pharmaceutical industry presents a united voice before the government and its budget proposals, individual firms appear to disagree over the latest tax proposal. India's Union Budget proposal contains a provision proposing a 16 percent excise tax on drug makers not located in tax-free zones. The Indian Drug Manufacturers' Association takes the position the tax should be cut in half for small and medium firms not normally found in tax-free zones. A unified industry proposed a reduction of excise taxes for all drug makers, but the Finance Ministry did not respond, so several large drug makers entered tax-free zones. (Click here for more
You may also be interested in...
Given its ever-growing role as a critical component of the global biopharma industry, you can’t afford not to be up to speed on Asia. This biweekly selection of insights from our experienced on-the-ground team will help.
Becton Dickinson will spend $1.2bn over the next four years to improve its drug-delivery device manufacturing capabilities. See what Eric Borin, president of BD, said about it here.
Pfizer is producing vaccine doses at scale now that it has buttoned down the manufacturing process.